Skip to main content
NCBI home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1988 Apr;398:65–80. doi: 10.1113/jphysiol.1988.sp017029

The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia.

H M Cox 1, A W Cuthbert 1, R Håkanson 1, C Wahlestedt 1
PMCID: PMC1191759  PMID: 3392683

Abstract

1. Neuropeptide Y (NPY), peptide YY (PYY) and, to a lesser extent, human pancreatic polypeptide (HPP) reduced short-circuit current (SCC) in a concentration-dependent manner in epithelial preparations of rat jejunum and descending colon. 2. From concentration-response curves in the jejunum EC50 values of 3 nM for PYY and 10 nM for NPY were obtained. HPP was much less potent, the threshold concentration being around 100 nM, and NPY 13-36 was inactive. 3. Repeated exposure of jejunal preparations to either NPY or PYY led to a rapid desensitization. Cross-desensitization to the actions of these two peptides was also observed. Neither tetrodotoxin (TTX) nor phentolamine affected responses to either NPY or PYY on the jejunum. 4. Responses to both peptides were inhibited by the presence of transport inhibitors, particularly diphenylamine-2-carboxylate (DPC, a chloride channel blocker) and piretanide (Na+-K+-2Cl- co-transport inhibitor). These results may indicate that the reduction in SCC caused by the neuropeptides is due to a net increase in chloride movement in the apical to basolateral direction. 5. 36Cl-flux studies identified an inhibition of chloride secretion as the predominant mechanism of action of NPY and PYY, together with a smaller stimulation of chloride absorption. No significant changes in the movement of 22Na were seen in either direction. 6. The cyclo-oxygenase inhibitors piroxicam (5 microM) and indomethacin (5 microM) significantly reduced the responses to both NPY and PYY in rat jejunum. From this and other evidence it was concluded that the peptides depended for their effect on the endogenous formation of eicosanoids, the prevention of which attenuated the SCC reduction due to the peptides.

Full text

PDF
65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böttcher G., Alumets J., Håkanson R., Sundler F. Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study. Regul Pept. 1986 Feb;13(3-4):283–291. doi: 10.1016/0167-0115(86)90046-7. [DOI] [PubMed] [Google Scholar]
  2. Böttcher G., Sjölund K., Ekblad E., Håkanson R., Schwartz T. W., Sundler F. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept. 1984 Jul;8(4):261–266. doi: 10.1016/0167-0115(84)90034-x. [DOI] [PubMed] [Google Scholar]
  3. Chang E. B., Field M., Miller R. J. alpha 2-Adrenergic receptor regulation of ion transport in rabbit ileum. Am J Physiol. 1982 Mar;242(3):G237–G242. doi: 10.1152/ajpgi.1982.242.3.G237. [DOI] [PubMed] [Google Scholar]
  4. Chronwall B. M., DiMaggio D. A., Massari V. J., Pickel V. M., Ruggiero D. A., O'Donohue T. L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience. 1985 Aug;15(4):1159–1181. doi: 10.1016/0306-4522(85)90260-x. [DOI] [PubMed] [Google Scholar]
  5. Cuthbert A. W., Halushka P. V., Margolius H. S., Spayne J. A. Mediators of the secretory response to kinins. Br J Pharmacol. 1984 Jul;82(3):597–607. doi: 10.1111/j.1476-5381.1984.tb10798.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cuthbert A. W., Hickman M. E. Indirect effects of adenosine triphosphate on chloride secretion in mammalian colon. J Membr Biol. 1985;86(2):157–166. doi: 10.1007/BF01870782. [DOI] [PubMed] [Google Scholar]
  7. Ekblad E., Håkanson R., Sundler F. VIP and PHI coexist with an NPY-like peptide in intramural neurones of the small intestine. Regul Pept. 1984 Dec;10(1):47–55. doi: 10.1016/0167-0115(84)90052-1. [DOI] [PubMed] [Google Scholar]
  8. Ekblad E., Winther C., Ekman R., Håkanson R., Sundler F. Projections of peptide-containing neurons in rat small intestine. Neuroscience. 1987 Jan;20(1):169–188. doi: 10.1016/0306-4522(87)90010-8. [DOI] [PubMed] [Google Scholar]
  9. Ekman R., Wahlestedt C., Böttcher G., Sundler F., Håkanson R., Panula P. Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept. 1986 Dec 22;16(2):157–168. doi: 10.1016/0167-0115(86)90059-5. [DOI] [PubMed] [Google Scholar]
  10. Everitt B. J., Hökfelt T., Terenius L., Tatemoto K., Mutt V., Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience. 1984 Feb;11(2):443–462. doi: 10.1016/0306-4522(84)90036-8. [DOI] [PubMed] [Google Scholar]
  11. Fehér E., Burnstock G. Electron microscopic study of neuropeptide Y-containing nerve elements of the guinea pig small intestine. Gastroenterology. 1986 Oct;91(4):956–965. doi: 10.1016/0016-5085(86)90700-6. [DOI] [PubMed] [Google Scholar]
  12. Field M., McColl I. Ion transport in rabbit ileal mucosa. 3. Effects of catecholamines. Am J Physiol. 1973 Oct;225(4):852–857. doi: 10.1152/ajplegacy.1973.225.4.852. [DOI] [PubMed] [Google Scholar]
  13. Fredholm B. B., Jansen I., Edvinsson L. Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand. 1985 Jul;124(3):467–469. doi: 10.1111/j.1748-1716.1985.tb07683.x. [DOI] [PubMed] [Google Scholar]
  14. Friel D. D., Miller R. J., Walker M. W. Neuropeptide Y: a powerful modulator of epithelial ion transport. Br J Pharmacol. 1986 Jun;88(2):425–431. doi: 10.1111/j.1476-5381.1986.tb10220.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Furness J. B., Costa M., Emson P. C., Håkanson R., Moghimzadeh E., Sundler F., Taylor I. L., Chance R. E. Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res. 1983;234(1):71–92. doi: 10.1007/BF00217403. [DOI] [PubMed] [Google Scholar]
  16. Furness J. B., Costa M., Keast J. R. Choline acetyltransferase- and peptide immunoreactivity of submucous neurons in the small intestine of the guinea-pig. Cell Tissue Res. 1984;237(2):329–336. doi: 10.1007/BF00217152. [DOI] [PubMed] [Google Scholar]
  17. Hubel K. A., Renquist K. S. Effect of neuropeptide Y on ion transport by the rabbit ileum. J Pharmacol Exp Ther. 1986 Jul;238(1):167–169. [PubMed] [Google Scholar]
  18. Kassis S., Olasmaa M., Terenius L., Fishman P. H. Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein. J Biol Chem. 1987 Mar 15;262(8):3429–3431. [PubMed] [Google Scholar]
  19. Lundberg J. M., Tatemoto K., Terenius L., Hellström P. M., Mutt V., Hökfelt T., Hamberger B. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4471–4475. doi: 10.1073/pnas.79.14.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miyachi Y., Jitsuishi W., Miyoshi A., Fujita S., Mizuchi A., Tatemoto K. The distribution of polypeptide YY-like immunoreactivity in rat tissues. Endocrinology. 1986 Jun;118(6):2163–2167. doi: 10.1210/endo-118-6-2163. [DOI] [PubMed] [Google Scholar]
  21. Saria A., Beubler E. Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo. Eur J Pharmacol. 1985 Dec 10;119(1-2):47–52. doi: 10.1016/0014-2999(85)90320-6. [DOI] [PubMed] [Google Scholar]
  22. Sundler F., Håkanson R., Ekblad E., Uddman R., Wahlestedt C. Neuropeptide Y in the peripheral adrenergic and enteric nervous systems. Int Rev Cytol. 1986;102:243–269. doi: 10.1016/s0074-7696(08)61277-2. [DOI] [PubMed] [Google Scholar]
  23. Sundler F., Moghimzadeh E., Håkanson R., Ekelund M., Emson P. Nerve fibers in the gut and pancreas of the rat displaying neuropeptide-Y immunoreactivity. Intrinsic and extrinsic origin. Cell Tissue Res. 1983;230(3):487–493. doi: 10.1007/BF00216194. [DOI] [PubMed] [Google Scholar]
  24. Tai Y. H., Decker R. A. Mechanisms of electrolyte transport in rat ileum. Am J Physiol. 1980 Mar;238(3):G208–G212. doi: 10.1152/ajpgi.1980.238.3.G208. [DOI] [PubMed] [Google Scholar]
  25. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2514–2518. doi: 10.1073/pnas.79.8.2514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5485–5489. doi: 10.1073/pnas.79.18.5485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wahlestedt C., Edvinsson L., Ekblad E., Håkanson R. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther. 1985 Sep;234(3):735–741. [PubMed] [Google Scholar]
  28. Wahlestedt C., Yanaihara N., Håkanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept. 1986 Feb;13(3-4):307–318. doi: 10.1016/0167-0115(86)90048-0. [DOI] [PubMed] [Google Scholar]
  29. Wiley J., Owyang C. Neuropeptide Y inhibits cholinergic transmission in the isolated guinea pig colon: mediation through alpha-adrenergic receptors. Proc Natl Acad Sci U S A. 1987 Apr;84(7):2047–2051. doi: 10.1073/pnas.84.7.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES